CS logo
small CS logo
Novant Health Cancer Institute

Charlotte, North Carolina, United States

About Novant Health Cancer Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Novant Health Cancer Institute


During the past decade, Novant Health Cancer Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Novant Health Cancer Institute" #1 sponsor was "Loxo Oncology, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Mersana Therapeutics" with 1 trials sponsored, "Molecular Templates, Inc." with 1 trials sponsored and "Monopar Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Cancer Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Novant Health Cancer Institute


According to Clinical.Site data, the most researched conditions in "Novant Health Cancer Institute" are "Chronic Lymphocytic Leukemia" (2 trials), "Small Lymphocytic Lymphoma" (2 trials), "Chemoradiotherapy-Induced Severe Oral Mucositis" (1 trials), "HER2-positive Solid Cancers" (1 trials) and "Leukemia, B-cell" (1 trials). Many other conditions were trialed in "Novant Health Cancer Institute" in a lesser frequency.

Clinical Trials Intervention Types at Novant Health Cancer Institute


Most popular intervention types in "Novant Health Cancer Institute" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Pirtobrutinib" (2 trials), "89Zr-Df-IAB22M2C" (1 trials), "Atezolizumab" (1 trials), "Bortezomib" (1 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Novant Health Cancer Institute


The vast majority of trials in "Novant Health Cancer Institute" are 7 trials for "All" genders.

Clinical Trials Status at Novant Health Cancer Institute


Currently, there are NaN active trials in "Novant Health Cancer Institute". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novant Health Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Novant Health Cancer Institute, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".